ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 312

$1.34M Total Retail Price of All Prescriptions

Rank: 5 out of 312

690 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 25,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 1,356 1,243 1 5
LEVOTHYROXINE SODIUM 1,218 1,154 2 6
METOPROLOL TARTRATE 1,102 1,055 3 8
SIMVASTATIN 981 882 4 3
OMEPRAZOLE 876 708 5 4
LISINOPRIL 796 714 6 1
AMLODIPINE BESYLATE 719 696 7 2
POTASSIUM CHLORIDE 635 551 8 19
SERTRALINE HCL 632 578 9 27
LOSARTAN POTASSIUM 612 587 10 22
WARFARIN SODIUM 536 536 11 11
LANTUS 514 420 12 43
HYDROCHLOROTHIAZIDE 489 436 13 16
KLOR-CON 8 483 419 10 14 202
METFORMIN HCL 431 393 15 13
ATORVASTATIN CALCIUM 350 324 16 10
TRAMADOL HCL 344 288 17 14
FENOFIBRATE 334 300 18 89
DONEPEZIL HCL 333 297 19 28
METOPROLOL SUCCINATE 319 293 20 12
GABAPENTIN 292 235 21 9
GLYBURIDE 290 254 R 22 101
ENALAPRIL MALEATE 282 259 23 142
CARVEDILOL 261 259 24 24
ATENOLOL 261 221 24 23
ISOSORBIDE DINITRATE 260 254 26 184
ISOSORBIDE MONONITRATE ER 243 243 27 42
HYDROCODONE-ACETAMINOPHEN 238 176 S3 28 7
NEXIUM 234 191 29 33
ZOLPIDEM TARTRATE 225 161 30 30
AZITHROMYCIN 221 190 31 66
POLYETHYLENE GLYCOL 3350 219 183 32 80
ALLOPURINOL 218 198 33 32
NOVOLOG 197 139 34 105
NAMENDA 190 176 35 39
CYMBALTA 185 124 36 50
CLOPIDOGREL 183 172 37 25
SPIRONOLACTONE 181 179 38 73
DIOVAN 179 168 39 54
TRAZODONE HCL 172 131 40 26
TRICOR 171 141 41 175
OXYCODONE-ACETAMINOPHEN 163 108 S2 42 17
ZETIA 154 143 43 100
CIPROFLOXACIN HCL 153 140 44 34
ALBUTEROL SULFATE 153 109 44 137
DIGOXIN 152 148 46 55
ALENDRONATE SODIUM 149 125 47 38
LOSARTAN-HYDROCHLOROTHIAZIDE 148 133 48 83
FENTANYL 142 102 S2 49 76
QUETIAPINE FUMARATE 140 118 50 52
GLIMEPIRIDE 138 138 51 51
LOVASTATIN 130 122 52 96
SYNTHROID 129 128 53 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 128 117 54 88
CLONIDINE HCL 128 122 54 67
MIRTAZAPINE 126 117 56 44
PANTOPRAZOLE SODIUM 123 111 57 37
PLAVIX 118 111 58 45
CRESTOR 111 107 59 47
LANTUS SOLOSTAR 110 105 60 93
PREDNISONE 110 105 60 29
DILTIAZEM 24HR CD 108 96 62 163
ACETAMINOPHEN-CODEINE 107 105 S3 63 235
RAMIPRIL 107 107 63 126
TEKTURNA 99 99 65 363
PRAVASTATIN SODIUM 97 75 66 18
FLUOXETINE HCL 90 68 67 71
ROPINIROLE HCL 89 69 68 120
BYSTOLIC 89 88 68 242
CEPHALEXIN 88 83 70 112
ESCITALOPRAM OXALATE 84 75 71 84
DILTIAZEM 24HR ER 84 84 71 176
AMITRIPTYLINE HCL 81 68 R 73 149
NIFEDIPINE ER 79 79 74 209
PROAIR HFA 78 61 75 41
AMOXICILLIN 77 70 76 189
TAMSULOSIN HCL 76 74 77 15
CITALOPRAM HBR 76 70 77 20
DIOVAN HCT 75 65 79 161
VALPROIC ACID 75 66 79 294
FLUOCINOLONE ACETONIDE 74 63 81 388
LEVETIRACETAM 73 61 82 82
COMBIVENT 71 35 83 193
NITROSTAT 70 57 84 181
MELOXICAM 70 65 84 57
TRIAMTERENE-HCTZ 68 68 86 87
NAPROXEN 67 49 87 143
FLUTICASONE PROPIONATE 67 49 87 59
CYCLOBENZAPRINE HCL 66 28 R 89 85
SPIRIVA 65 64 90 35
ADVAIR DISKUS 64 62 91 46
PAROXETINE HCL 64 64 91 78
SINGULAIR 63 42 93 154
DILTIAZEM ER 62 62 94 416
AMIODARONE HCL 61 61 95 133
KETOCONAZOLE 60 58 96 150
INSULIN SYRINGE 60 59 96 125
DIVALPROEX SODIUM 60 57 96 65
PHENYTOIN SODIUM EXTENDED 60 47 96 141
NADOLOL 59 56 100 424
METOLAZONE 58 58 101 425
TRIAMCINOLONE ACETONIDE 58 57 101 97
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 56 103 234
EXELON 55 55 104 115
NOVOLIN 70-30 55 36 104 288
IBUPROFEN 55 35 104 148
TRILIPIX 55 51 104 438
SEROQUEL 54 45 108 204
PEN NEEDLE 54 33 108 109
LANSOPRAZOLE 54 50 108 299
OXYBUTYNIN CHLORIDE ER 53 41 111 62
MONTELUKAST SODIUM 53 41 111 214
CARBIDOPA-LEVODOPA 51 51 113 58
JANUVIA 51 38 113 90
BUSPIRONE HCL 50 28 115 127
LORAZEPAM 50 45 115 185
CEFTRIAXONE 50 45 115 458
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.